Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$75.21 +0.49 (+0.65%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$74.80
▼
$76.55
50-Day Range
$69.16
▼
$76.66
52-Week Range
$53.66
▼
$76.89
Volume
70,417 shs
Average Volume
21,773 shs
Market Capitalization
$238.69 million
P/E Ratio
22.88
Dividend Yield
1.65%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products, Inc. (NASDAQ: UTMD) develops, manufactures and markets disposable medical devices used in hospital and clinical settings. The company focuses primarily on products for obstetrics, gynecology, neonatal care, electrosurgery and related surgical procedures.

Its product portfolio includes fetal monitoring electrodes and catheters, intrauterine pressure catheters, uterine manipulators, cervical dilators, neonatal respiratory products, electrosurgical instruments, grounding pads, biopsy devices and other specialized disposable instruments. These products are designed for use by physicians, nurses and other healthcare professionals.

Founded in 1978 and headquartered in Midvale, Utah, Utah Medical Products serves customers in the United States and international markets. The company sells its products through direct sales and distributors, with international operations and distribution supporting customers in regions including Europe and other global markets.

AI Generated. May Contain Errors.

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

UTMD MarketRank™: 
1.648781134075 of 5 stars

Utah Medical Products scored higher than 33% of companies evaluated by MarketBeat, and ranked 761st out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 22.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 22.97, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.47.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    5.19% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 4.79.
  • Change versus previous month

    Short interest in Utah Medical Products has recently decreased by 11.77%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.65%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 37.80%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Utah Medical Products this week, compared to 1 article on an average week.
  • MarketBeat Follows

    2 people have added Utah Medical Products to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
Utah Medical Launches Tender Offer
Utah Medical Products Inc's Dividend Analysis
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the beginning of 2026. Since then, UTMD shares have increased by 34.6% and is now trading at $75.3250.

Utah Medical Products, Inc. (NASDAQ:UTMD) posted its quarterly earnings data on Thursday, October, 22nd. The medical instruments supplier reported $0.88 earnings per share for the quarter. Utah Medical Products had a net margin of 29.04% and a trailing twelve-month return on equity of 8.74%.

Top institutional shareholders of Utah Medical Products include Cardinal Capital Management (0.93%).
View institutional ownership trends
.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include CME Group (CME), Enphase Energy (ENPH), Accenture (ACN), Avery Dennison (AVY), Ford Motor (F), FactSet Research Systems (FDS) and Pacific Gas & Electric (PCG).

Company Calendar

Record date for 10/5 Dividend
9/17/2026
Ex-Dividend for 10/5 Dividend
9/17/2026
Dividend Payable
10/05/2026
Today
10/22/2026
Last Earnings
10/22/2026
Next Earnings (Estimated)
10/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
152
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.28
Trailing P/E Ratio
22.88
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
29.04%
Pretax Margin
35.68%
Return on Equity
8.74%
Return on Assets
8.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
48.62
Quick Ratio
44.27

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
6.20
Cash Flow
$4.46 per share
Price / Cash Flow
16.83
Book Value
$37.23 per share
Price / Book
2.02

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$238.69 million
Optionable
Not Optionable
Beta
0.38

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 10/22/2026 by MarketBeat.com Staff.
From Our Partners